Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
769.450.1%
QQQ
717.500.2%
BTC/USD
79129.101.5062%
DIA
532.880.22%
GLD
406.530.06%
TLT
82.240.04%

Dogwood Therapeutics Inc

DWTXNASDAQ
Trade with Public
Trade with Public
$2.29
-0.07-2.97%
At close: Sep 4, 5:00 PM EST
$2.13
-0.16-6.99%
After Hours: Sep 4, 4:11 AM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentCompareStock Report

Dogwood Therapeutics Analyst Price Targets

Wall Street analyst price targets and consensus rating for Dogwood Therapeutics (DWTX).

Price Target Range — 4 Quarters

Analyst Consensus — 1 Analysts

1Buy
Consensus RatingBuy# Analysts1Avg. Consensus PT$12Upside to Avg. PT+463.4%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
May 19, 2026HC Wainwright & Co.Sean LeeMaintainedBuy$12
Apr 27, 2026HC Wainwright & Co.Sean LeeMaintainedBuy$12
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Dogwood Therapeutics, Maintains $12 Price Target

HC Wainwright & Co. analyst Sean Lee reiterates Dogwood Therapeutics (NASDAQ:DWTX) with a Buy and maintains $12 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Dogwood Therapeutics, Maintains $12 Price Target

HC Wainwright & Co. analyst Sean Lee reiterates Dogwood Therapeutics (NASDAQ:DWTX) with a Buy and maintains $12 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Dogwood Therapeutics, Maintains $12 Price Target

HC Wainwright & Co. analyst Sean Lee reiterates Dogwood Therapeutics (NASDAQ:DWTX) with a Buy and maintains $12 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Dogwood Therapeutics, Maintains $12 Price Target

HC Wainwright & Co. analyst Sean Lee reiterates Dogwood Therapeutics (NASDAQ:DWTX) with a Buy and maintains $12 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Dogwood Therapeutics, Raises Price Target to $12

HC Wainwright & Co. analyst Sean Lee maintains Dogwood Therapeutics (NASDAQ:DWTX) with a Buy and raises the price target from $10 to $12.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Upgrades Dogwood Therapeutics to Buy, Announces $10 Price Target

HC Wainwright & Co. analyst Sean Lee upgrades Dogwood Therapeutics (NASDAQ:DWTX) from Neutral to Buy and announces $10 price target.
Benzinga Newsdesk

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved